LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026)
LENZ Therapeutics (LENZ) reported Operating Leases of $237000.0 for Q1 2026, down 64.78% year-over-year from $673000.0 in Q1 2025, and down 32.29% on a QoQ basis from $350000.0 in Q4 2025.
LENZ Therapeutics (LENZ) has 6 years of Operating Leases data on file, last reported at $237000.0 in Q1 2026.
- Quarterly Operating Leases fell 64.78% year-over-year to $237000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $237000.0 (down 64.78% YoY) and the FY2025 annual result came in at $350000.0, down 57.0% from the prior year.
- Operating Leases slipped to $237000.0 in Q1 2026 per LENZ's latest filing, from $350000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $50.6 million in Q2 2023 and bottomed at $192000.0 in Q4 2023.
- The 5-year median for Operating Leases is $1.4 million (2023), against an average of $7.1 million.
- The widest annual swing landed in 2023, when Operating Leases jumped 1888.0%; it then sank 97.12% in 2024.
- Tracing LENZ's Operating Leases over 5 years: stood at $1.7 million in 2022, then tumbled by 89.02% to $192000.0 in 2023, then soared by 323.96% to $814000.0 in 2024, then sank by 57.0% to $350000.0 in 2025, then sank by 32.29% to $237000.0 in 2026.
- Per Business Quant, the three latest LENZ Operating Leases figures stand at $237000.0 (Q1 2026), $350000.0 (Q4 2025), and $461000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | 461,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Mar 31, 2025 | 673,000.00 |
| Dec 31, 2024 | 814,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 296,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 49.70 Mn |
| Jun 30, 2023 | 50.60 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 4.68 Mn |